These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33099283)
1. Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry. Guillet B; Cayla G; Lebreton A; Trillot N; Wibaut B; Falaise C; Castet S; Gautier P; Claeyssens S; Schved JF Thromb Haemost; 2021 Mar; 121(3):287-296. PubMed ID: 33099283 [TBL] [Abstract][Full Text] [Related]
2. Debates Surrounding the Use of Antithrombotic Therapy in Hemophilic Patients with Cardiovascular Disease: Best Strategies to Minimize Severe Bleeding Risk. Badulescu OV; Scripcariu DV; Badescu MC; Ciocoiu M; Vladeanu MC; Plesoianu CE; Bojan A; Iliescu-Halitchi D; Tudor R; Huzum B; Bararu Bojan I Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063087 [TBL] [Abstract][Full Text] [Related]
3. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF. Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK; Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH; Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056 [TBL] [Abstract][Full Text] [Related]
6. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry". Fischer Q; Georges JL; Le Feuvre C; Sharma A; Hammoudi N; Berman E; Cohen S; Jolivet I; Silvain J; Helft G Int J Cardiol; 2018 Aug; 264():64-69. PubMed ID: 29776575 [TBL] [Abstract][Full Text] [Related]
7. Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophilia. Mannucci PM Expert Opin Pharmacother; 2012 Mar; 13(4):505-10. PubMed ID: 22332913 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents. Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773 [TBL] [Abstract][Full Text] [Related]
9. Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. Redfors B; Kirtane AJ; Pocock SJ; Ayele GM; Deliargyris EN; Mehran R; Stone GW; Généreux P J Am Coll Cardiol; 2016 Dec; 68(24):2608-2618. PubMed ID: 27978944 [TBL] [Abstract][Full Text] [Related]
10. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related]
11. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention. Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T J Cardiol; 2019 Jun; 73(6):479-487. PubMed ID: 30598387 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK; JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873 [TBL] [Abstract][Full Text] [Related]
13. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406 [TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®. Ghanbari H; Nallamothu BK; Wang Y; Curtis JP J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637345 [TBL] [Abstract][Full Text] [Related]
15. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005 [TBL] [Abstract][Full Text] [Related]
16. Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A. Zhao Y; Hu Y; Jin J; Zhao X; Wang X; Wu R; Wu D; Yang R; Yang F; Hu Q; Wang J; Fang H; Engl W Clin Appl Thromb Hemost; 2021; 27():1076029621989811. PubMed ID: 33587652 [TBL] [Abstract][Full Text] [Related]
17. Edoxaban versus warfarin in patients with atrial fibrillation. Giugliano RP; Ruff CT; Braunwald E; Murphy SA; Wiviott SD; Halperin JL; Waldo AL; Ezekowitz MD; Weitz JI; Špinar J; Ruzyllo W; Ruda M; Koretsune Y; Betcher J; Shi M; Grip LT; Patel SP; Patel I; Hanyok JJ; Mercuri M; Antman EM; N Engl J Med; 2013 Nov; 369(22):2093-104. PubMed ID: 24251359 [TBL] [Abstract][Full Text] [Related]
18. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study]. Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427 [No Abstract] [Full Text] [Related]
19. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). Mennuni MG; Halperin JL; Bansilal S; Schoos MM; Theodoropoulos KN; Meelu OA; Sartori S; Giacoppo D; Bernelli C; Moreno PR; Krishnan P; Baber U; Lucarelli C; Dangas GD; Sharma SK; Kini AS; Tamburino C; Chieffo A; Colombo A; Presbitero P; Mehran R Am J Cardiol; 2015 Jul; 116(1):37-42. PubMed ID: 25956624 [TBL] [Abstract][Full Text] [Related]
20. Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry. Le Heuzey JY; Bassand JP; Berneau JB; Cozzolino P; D'Angiolella L; Doucet B; Mantovani LG; Martelet M; Mouallem J; Muller JJ; Pieper K; Arch Cardiovasc Dis; 2018 Dec; 111(12):749-757. PubMed ID: 29861295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]